169 related articles for article (PubMed ID: 37500150)
1. Treatment Challenges in Soft Tissue Reconstruction in Patients With MRONJ - The Nasolabial Flap.
Dudde F; Barbarewicz F; Henkel KO
Anticancer Res; 2023 Aug; 43(8):3709-3713. PubMed ID: 37500150
[TBL] [Abstract][Full Text] [Related]
2. Nasolabial Flap Improves Healing in Medication-Related Osteonecrosis of the Jaw.
Lemound J; Muecke T; Zeller AN; Lichtenstein J; Eckardt A; Gellrich NC
J Oral Maxillofac Surg; 2018 Apr; 76(4):877-885. PubMed ID: 29104029
[TBL] [Abstract][Full Text] [Related]
3. Surgical treatment of medication-related osteonecrosis of the upper jaw: Case series.
Aljohani S; Troeltzsch M; Hafner S; Kaeppler G; Mast G; Otto S
Oral Dis; 2019 Mar; 25(2):497-507. PubMed ID: 30325561
[TBL] [Abstract][Full Text] [Related]
4. Interventions for managing medication-related osteonecrosis of the jaw.
Beth-Tasdogan NH; Mayer B; Hussein H; Zolk O
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD012432. PubMed ID: 28983908
[TBL] [Abstract][Full Text] [Related]
5. Surgical treatment of advanced medication-related osteonecrosis of the jaws: Comparison of soft tissue closure techniques and evaluation of side effects.
Ahrenbog G; Gottsauner M; Meier JK; Ettl T; Reichert TE; Klingelhöffer C
J Craniomaxillofac Surg; 2020 Sep; 48(9):896-901. PubMed ID: 32811717
[TBL] [Abstract][Full Text] [Related]
6. Bisphosphonate-associated osteonecrosis of the mandible: reliable soft tissue reconstruction using a local myofascial flap.
Lemound J; Eckardt A; Kokemüller H; von See C; Voss PJ; Tavassol F; Rücker M; Rana M; Gellrich NC
Clin Oral Investig; 2012 Aug; 16(4):1143-52. PubMed ID: 21818568
[TBL] [Abstract][Full Text] [Related]
7. Surgical treatment of severe medication-related osteonecrosis of the jaw.
Feng Z; An J; Zhang Y; He Y
Hua Xi Kou Qiang Yi Xue Za Zhi; 2023 Feb; 41(1):43-51. PubMed ID: 38596940
[TBL] [Abstract][Full Text] [Related]
8. [Application of double-layer soft tissue suture closure technique in the surgical treatment of patients with mandible medication-related osteonecrosis of the jaw of early and medium stages].
Zhou Y; Zhao N; Huang H; Li Q; Guo C; Guo Y
Beijing Da Xue Xue Bao Yi Xue Ban; 2024 Feb; 56(1):51-56. PubMed ID: 38318896
[TBL] [Abstract][Full Text] [Related]
9. Bosutinib-induced osteonecrosis of the jaw in a patient with chronic myeloid leukemia: a case report.
Myoken Y; Fujita Y; Imanaka R; Toratani S
Oral Maxillofac Surg; 2021 Sep; 25(3):421-425. PubMed ID: 33411057
[TBL] [Abstract][Full Text] [Related]
10. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
[TBL] [Abstract][Full Text] [Related]
11. Microsurgical Reconstruction of the Jaws Using Vascularised Free Flap Technique in Patients with Medication-Related Osteonecrosis: A Systematic Review.
Sacco R; Sacco N; Hamid U; Ali SH; Singh M; Blythe JSJ
Biomed Res Int; 2018; 2018():9858921. PubMed ID: 29977926
[TBL] [Abstract][Full Text] [Related]
12. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
13. The role of mylohyoid flap in the treatment of bisphosphonate-related osteonecrosis of the jaws.
Mücke T; Koerdt S; Jung M; Mitchell DA; Wolff KD; Kesting MR; Loeffelbein DJ
J Craniomaxillofac Surg; 2016 Apr; 44(4):369-73. PubMed ID: 26857755
[TBL] [Abstract][Full Text] [Related]
14. Successful New Dental Implant Installation in a Healed Site of Medication-Related Osteonecrosis of the Jaw: A Case Report.
Lee JY; Park JU; Lee SY
J Oral Implantol; 2023 Apr; 49(2):117-123. PubMed ID: 37025054
[TBL] [Abstract][Full Text] [Related]
15. [Position paper on medication-related osteonecrosis of the jaw (MRONJ)].
Svejda B; Muschitz Ch; Gruber R; Brandtner Ch; Svejda Ch; Gasser RW; Santler G; Dimai HP
Wien Med Wochenschr; 2016 Feb; 166(1-2):68-74. PubMed ID: 26847441
[TBL] [Abstract][Full Text] [Related]
16. Reconstruction of defects caused by bisphosphonate-induced osteonecrosis of the jaws.
Marx RE
J Oral Maxillofac Surg; 2009 May; 67(5 Suppl):107-19. PubMed ID: 19371821
[TBL] [Abstract][Full Text] [Related]
17. Sclerotic bone: a sign of bone reaction in patients with medication related osteonecrosis of the jaw.
Obermeier KT; Dewenter I; Malenova Y; Fliefel R; Kaeppler G; Otto S
Sci Rep; 2024 Apr; 14(1):7914. PubMed ID: 38575664
[TBL] [Abstract][Full Text] [Related]
18. Medication-related osteonecrosis of the mandible: an unusual presentation and treatment.
Rothweiler R; Voss PJ; Schmelzeisen R; Metzger MC
Int J Oral Maxillofac Surg; 2021 Apr; 50(4):511-515. PubMed ID: 32847710
[TBL] [Abstract][Full Text] [Related]
19. Comparing the Surgical Response of Bisphosphonate-Related Versus Denosumab-Related Osteonecrosis of the Jaws.
Palla B; Burian E; Deek A; Scott C; Anderson J; Callahan N; Carlson ER
J Oral Maxillofac Surg; 2021 May; 79(5):1045-1052. PubMed ID: 33358707
[TBL] [Abstract][Full Text] [Related]
20. Evaluation of surgical outcome and influencing risk factors in patients with medication-related osteonecrosis of the jaws.
Klingelhöffer C; Zeman F; Meier J; Reichert TE; Ettl T
J Craniomaxillofac Surg; 2016 Oct; 44(10):1694-1699. PubMed ID: 27591091
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
